P255 Secukinumab provides sustained improvement in nail...

P255 Secukinumab provides sustained improvement in nail psoriasis and inhibition of radiographic progression in PsA patients with nail phenotype: 52-week results from a Phase 3 study

Kirkham, Bruce, Nash, Peter, Mease, Philip J, Balsa, Alejandro C, Singhal, Atul, Quebe-Fehling, Erhard, Pricop, Luminita, Gaillez, Corine
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
59
Journal:
Rheumatology
DOI:
10.1093/rheumatology/keaa111.248
Date:
April, 2020
File:
PDF, 68 KB
2020
Conversion to is in progress
Conversion to is failed